TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 315 filers reported holding TANDEM DIABETES CARE INC in Q4 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $44,765,000 | -4.0% | 467,861 | +13.9% | 3.30% | -18.3% |
| Q3 2020 | $46,616,000 | +10.9% | 410,712 | -3.3% | 4.04% | +3.1% |
| Q2 2020 | $42,018,000 | +12.9% | 424,767 | -26.6% | 3.92% | +5.7% |
| Q1 2020 | $37,217,000 | -0.5% | 578,359 | -7.8% | 3.71% | +42.6% |
| Q4 2019 | $37,389,000 | +26.3% | 627,225 | +24.9% | 2.60% | +13.7% |
| Q3 2019 | $29,607,000 | -10.0% | 501,985 | -1.5% | 2.29% | -4.6% |
| Q2 2019 | $32,897,000 | +8.6% | 509,876 | +6.9% | 2.40% | +8.1% |
| Q1 2019 | $30,284,000 | +35.6% | 476,919 | -18.9% | 2.22% | +16.3% |
| Q4 2018 | $22,335,000 | +4.3% | 588,221 | +17.7% | 1.91% | +27.9% |
| Q3 2018 | $21,414,000 | +800.5% | 499,855 | +362.8% | 1.49% | +694.1% |
| Q2 2018 | $2,378,000 | – | 108,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |